Taking
advantage of the excellent trans-cleavage activity, CRISPR-based
diagnostics (CRISPR-Dx) has shown great promise in molecular diagnostics.
However, the single-stranded DNA reporter of the current CRISPR-Dx
suffers from poor stability and limited sensitivity, which make their
application in complex biological environments difficult. Herein,
we, for the first time, explore the trans-cleavage activity of CRISPR/Cas12a
toward the substrate on gold nanoparticles and apply the new phenomenon
to develop a spherical nucleic acid (SNA) reporter for stable and
sensitive CRISPR-Dx biosensing. By anchoring the DNA substrate on
gold nanoparticles, we discovered different trans-cleavage activities
of different types of the Cas12a system (e.g., LbCas12a and AsCas12a)
on a nanoparticle surface. The further study suggests that the trans-cleavage
activity of LbCas12a on the nanoparticle surface is highly dependent
on the density and length of DNA strands. Based on these interesting
discoveries, we furthermore develop SNA reporter-based fluorescent
CRISPR-Dx for stable and sensitive biosensing application. Compared
to traditional ssDNA reporters, the SNA reporter exhibits improved
stability, which enables the stable application in a complex serum
environment. In addition, the SNA reporter system with tunable density
exhibits high sensitivity with a detection limit of 10 fM, which is
about 2 orders of magnitude lower than that of the ssDNA reporter
system. Finally, the practical application of SNA reporter-based CRISPR-Dx
in clinical serum was successfully achieved. These results indicate
their significant potential in future research on biology science
and medical diagnoses.